Back to Journals » OncoTargets and Therapy » Volume 11
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
TIM-3, a promising target for cancer immunotherapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
36,316 | Dovepress* | 14,937+ | 2,175 | 17,112 | |
PubMed Central* | 21,379 | 2,931 | 24,310 | ||
Totals | 36,316 | 5,106 | 41,422 | ||
*Since 16 October 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 1 | 5 |
View citations on PubMed Central and Google Scholar